traded as nasdaq copenhagen lun industry pharmaceuticals founded 1915 headquarters copenhagen denmark key people h kan bj rklund chairman k re schultz ceo may 2015 present revenue dkk 15.2 billion 2013 1 operating income dkk 1.6 billion 2013 1 profit dkk 855 million 2013 1 total assets dkk 23.7 billion end 2013 1 total equity dkk 13.5 billion end 2013 1 number of employees 5 530 average 2013 1 website lundbeck.com h. lundbeck a s commonly known simply as lundbeck is a danish international pharmaceutical company engaged in the research and development production marketing and sale of drugs for the treatment of disorders in the central nervous system cns including depression schizophrenia alzheimer s disease parkinson s disease huntington s disease epilepsy and insomnia . 2 headquartered in copenhagen denmark lundbeck has international production facilities in denmark italy and france and affiliates or sales offices in 57 countries . lundbeck employs around 5.500 people globally as of 2013 and the company s products are registered in more than 100 countries worldwide . 2 in 2013 the company s revenue was dkk 15.2 billion 2.04 billion . lundbeck is listed on the copenhagen stock exchange cse . lundbeck is a full member of the european federation of pharmaceutical industries and associations efpia and of the international federation of pharmaceutical manufacturers and associations ifpma contents 1 history 2 key products 2.1 products under development 3 controversy 4 2013 fine 5 see also 6 references 7 external links history edit the company was founded by hans lundbeck in 1915 and was initially a trading company supplying a variety of goods to the danish market including machinery for manufacturing aluminium foil artificial sweeteners and photographic equipment . lundbeck entered the pharmaceutical market in 1924 importing medicines and cosmetics from companies based in other european and american countries . by the late 1930s lundbeck had begun to produce its own medicinal products and had established its own research department . production continued during the second world war although it was limited due to a lack of raw materials . after the war lundbeck continued to grow and in 1957 the company introduced truxal chlorprothixene for the treatment of schizophrenia entering the market for brain disorders . in 1954 the lundbeck foundation was established to maintain and expand the activities of lundbeck group and also to provide funding for scientific research of the highest quality . from the late 1970s and up through the 1980s lundbeck diverted its old agency business and thus became a dedicated pharmaceutical company focusing on the production of drugs used to treat disorders and diseases of the central nervous system . in 1989 lundbeck launched the antidepressant celexa citalopram which became the cornerstone for the company s international expansion and in 2009 lundbeck bought ovation and established a commercial platform in the usa . 2 in 2012 to focus on newer strategic cns products lundbeck sold a portfolio of non core products to recordati s.p.a. recordati rare diseases . 3 in 2014 lundbeck acquired chelsea therapeutics for up to 658 million . 4 key products edit key products are the serotonin modulator and stimulator trintellix brintellix selective serotonin reuptake inhibitor lexapro escitalopram and antidementia agent ebixa memantine . lundbeck manufactures drugs as brand name inn drug class indication s notes abilify maintena aripiprazole atypical antipsychotic maintenance treatment of schizophrenia co marketed with otsuka azilect rasagiline maob inhibitor parkinson s disease in some countries co marketed with teva brintellix trintellix vortioxetine sri multimodal antidepressant described as serotonin modulator and stimulator 5 major depressive disorder co marketed in the usa with takeda who also has rights to japan cipramil celexa seropram citalopram ssri major depressive disorder anxiety disorders cipralex lexapro escitalopram ssri major depressive disorder generalized anxiety disorder gad s enantiomer of citalopram clopixol cisordinol zuclopenthixol high potency typical antipsychotic of thioxanthene class psychoses including schizophrenia cis isomer of clopenthixol a predecessor drug deanxit flupentixol melitracen typical antipsychotic tricyclic antidepressant moderate to severe depression associated with anxiety and or agitation ebixa ebix memantine nmda receptor antagonist alzheimer s disease fluanxol flupentixol high potency thioxanthene typical antipsychotic psychoses including schizophrenia modiodal modafinil eugeroic wakefulness promoting agent narcolepsy shift work sleep disorder obstructive sleep apnea hypopnea nortrilen sensoval nortriptyline tricyclic antidepressant depression nocturnal enuresis active metabolite of amitriptyline onfi clobazam benzodiazepine anticonvulsant and anxiolytic seizures associated with lennox gastaut syndrome outside the us approved for anxiety and treatment resistant epilepsy under the brand name frisium rexulti brexpiprazole atypical antipsychotic the so called serotonin dopamine activity modulator schizophrenia major depressive disorder as an adjunctive treatment marketed in partnership with otsuka sabril vigabatrin anticonvulsant gaba transaminase inhibitor treatment resistant epilepsy complex partial seizures and west syndrome use is restricted to resistant and refractory epilepsy due to the risk of irreversible vision loss 6 saphris sycrest asenapine atypical antipsychotic psychoses including schizophrenia acute and maintenance treatment of bipolar i disorder in some countries like philippines latvia and russian federation marketed by or co marketed with merck & co. merck sharp & dohme saroten sarotex redomex amitriptyline tricyclic antidepressant depression both unipolar and bipolar anxiety disorders eating disorders migraine prophylaxis insomnia etc. selincro nalmefene opioid receptor antagonist reduction of alcohol consumption in alcohol dependence in combination with psychosocial support only be used in patients with high drinking risk at initial assessment and 2 weeks later in those who do not have physical withdrawal symptoms or require immediate detoxification serdolect serlect sertindole atypical antipsychotic psychoses including schizophrenia treanda bendamustine nitrogen mustard alkylating agent chronic lymphocytic leukemia co marketed with teva truxal chlorprothixene thioxanthene typical antipsychotic psychosis including schizophrenia in some other countries approved for menopausal depression insomnia and resistant nausea vomiting xenazine nitoman tetrabenazine vmat2 inhibitor chorea associated with huntington s disease tic disorders tardive dyskinesia products under development edit intravenous formulation of carbamazepine for epilepsy idalopirdine lu ae58054 a 5 ht6 antagonist for alzheimer s disease brexpiprazole for schizophrenia adjunct add and alzheimer s disease aripiprazole for bipolar i disorder vortioxetine for adult adhd lundbeck homepage pipeline controversy edit lundbeck formerly held the only license to manufacture pentobarbital nembutal in the united states . 7 the drug is commonly used for execution by lethal injection in the united states either as part of a three drug cocktail or by itself . after coming under criticism for not adding an end user agreement to prevent importers from selling nembutal to american prisons for use in executions lundbeck announced that it would not sell nembutal to prisons in u.s. states that carry out executions . by introducing a new distribution system nembutal will be supplied exclusively through a specialty pharmacy drop ship program that will deny distribution of the product to prisons in u.s. states currently active in carrying out the death penalty by lethal injection . 8 in december 2011 lundbeck divested a portfolio of products including nembutal to us pharmaceutical company akorn inc. as part of the agreement akorn committed to continue with lundbeck s restricted distribution program for nembutal which was implemented to restrict the use of the product in the us . 2013 fine edit on june 19 2013 the european commission imposed a fine of 93.8 million on lundbeck and fined several producers of generic pharmaceuticals a total of 52.2 million after lundbeck made agreements in 2002 with the other companies to delay less expensive generics of lundbeck s citalopram from entering the market . in return for the ability to maintain a monopoly on the drug s manufacture lundbeck offered payments and other kickbacks . 9 see also edit tarenflurbil which the company had arranged for eu distribution rights on prior to termination of its development by myriad . references edit a b c d e f annual report 2013 pdf . lundbeck . retrieved 9 october 2014 . a b c lundbeck.com h. lundbeck a s december 14 2012 . corporate release no 487 . lundbeck to divest a portfolio of non core products as part of its strategy to focus on newer strategic cns products pdf . retrieved 29 july 2014 . http www.genengnews.com gen news highlights h lundbeck acquiring chelsea therapeutics for up to 658m 81249845 lundbeck s serotonin modulator and stimulator lu aa21004 how novel how good glg news . sabril vigabatrin tablets . prescribing information . lundbeck inc. 2012 . revised february 2012 . 1 execution drug still available after lundbeck shuns end user agreements . the copenhagen post . 1 april 2011 . retrieved 3 july 2011 . lundbeck seeks to curb use of drug in executions . the wall street journal . 1 july 2011 . retrieved 3 july 2011 . http europa.eu rapid press release ip 13 563 en.htm external links edit official website the lundbeck institute v t e omx copenhagen 20 companies of denmark march 2016 a.p. m ller m rsk carlsberg chr . hansen coloplast danske bank dsv flsmidth & co. genmab gn store nord iss jyske bank nordea novo nordisk novozymes pandora tdc tryg vestas wind systems william demant retrieved from https en.wikipedia.org w index.php title lundbeck & oldid 740139566 categories pharmaceutical companies of denmarkcompanies based in copenhagenlife science companies based in copenhagenvalbypharmaceutical companies established in 1915danish brands navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages danskdeutscheesti fran ais norsk bokm lpolskirom n suomisvenska edit links this page was last modified on 19 september 2016 at 08 30 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view